Skip to content

Clinical trials

Completed Diabetes Mellitus trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Status: Completed Country / region: China Clear all

194 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20032
20043
20053
20064
20075
200812
200911
20108
201113
20124
20139
20147
20154
201610
201716
20186
20199
20204
20219
202217
202311
202413
202511

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed194

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S44
Eli Lilly and Company7
AstraZeneca5
Chinese University of Hong Kong5
Jiangsu HengRui Medicine Co., Ltd.4
Shanghai 6th People's Hospital4
Shanghai Jiao Tong University School of Medicine4
Bayer3
China National Center for Cardiovascular Diseases3
Gan and Lee Pharmaceuticals, USA3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus194
Diabetes Mellitus, Type 274
Diabetes Mellitus, Type 110
Hypertension10
Insulin Resistance9
Obesity8
Coronary Artery Disease5
Metabolic Diseases5
Renal Insufficiency, Chronic5
Cardiovascular Diseases4

Trials

Showing 1 to 25 of 194. Each trial links to its page on Pharma Observatory.

94 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.